Skip to main content
AAN.com

Abstract

Between 1972 and 1988, 145 deaths occurred among 3,126 patients attending the Multiple Sclerosis (MS) Clinics in Vancouver, British Columbia (N = 1,583), and London, Ontario (N = 1,543). We could determine the exact cause of death in 82.1% of cases (119 of 145). Of the 119 patients for whom the cause of death was known, 56 deaths (47.1%) were directly attributed to complications of MS. Of the remaining 63 deaths, 18 (28.6%) were suicides, 19 (30.2%) were due to malignancy, 13 (20.6%) to an acute myocardial infarction, seven (11.1%) to stroke, and the remainder (9.5%) to miscellaneous causes, of which two may have been suicides. The proportion of suicides among MS deaths was 7.5 times that for the age-matched general population, and the proportion of MS deaths from malignancy was 0.67 times that for the age-matched general population. The proportion of deaths due to malignancy and stroke was the same for the MS patients and the age-matched general population.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 41Number 8August 1991
Pages: 1193
PubMed: 1866003

Publication History

Published online: August 1, 1991
Published in print: August 1991

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

A. D. Sadovnick, PhD
Multiple Sclerosis Clinic (Dr. Sadovnick, K. Eisen, and Dr. Paty), University Hospital-UBC Site and the Department of Medical Genetics (Dr. Sadovnick), University of British Columbia, Vancouver, BC; and Multiple Sclerosis Clinic (Dr. Ebers), University Hospital, University of Western Ontario, London, ON, Canada.
K. Eisen, RN
Multiple Sclerosis Clinic (Dr. Sadovnick, K. Eisen, and Dr. Paty), University Hospital-UBC Site and the Department of Medical Genetics (Dr. Sadovnick), University of British Columbia, Vancouver, BC; and Multiple Sclerosis Clinic (Dr. Ebers), University Hospital, University of Western Ontario, London, ON, Canada.
G. C. Ebers, MD
Multiple Sclerosis Clinic (Dr. Sadovnick, K. Eisen, and Dr. Paty), University Hospital-UBC Site and the Department of Medical Genetics (Dr. Sadovnick), University of British Columbia, Vancouver, BC; and Multiple Sclerosis Clinic (Dr. Ebers), University Hospital, University of Western Ontario, London, ON, Canada.
D. W. Paty, MD
Multiple Sclerosis Clinic (Dr. Sadovnick, K. Eisen, and Dr. Paty), University Hospital-UBC Site and the Department of Medical Genetics (Dr. Sadovnick), University of British Columbia, Vancouver, BC; and Multiple Sclerosis Clinic (Dr. Ebers), University Hospital, University of Western Ontario, London, ON, Canada.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Risk factors and long-term outcomes of oropharyngeal dysphagia in persons with multiple sclerosis: a systematic review protocol, Systematic Reviews, 13, 1, (2024).https://doi.org/10.1186/s13643-024-02530-3
    Crossref
  2. Multiple sclerosis and vascular nexus: A systematic review and meta-analysis of incidence and mortality, Revue Neurologique, (2024).https://doi.org/10.1016/j.neurol.2024.10.007
    Crossref
  3. Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course, Neurologic Clinics, 42, 1, (229-253), (2024).https://doi.org/10.1016/j.ncl.2023.06.007
    Crossref
  4. Suicidal ideation in the year following diagnosis of relapsing-remitting multiple sclerosis: A longitudinal perspective, Multiple Sclerosis and Related Disorders, 91, (105904), (2024).https://doi.org/10.1016/j.msard.2024.105904
    Crossref
  5. Suicidal ideation in people with multiple sclerosis and its association with coping self-efficacy, Multiple Sclerosis and Related Disorders, 87, (105677), (2024).https://doi.org/10.1016/j.msard.2024.105677
    Crossref
  6. Asthma and chronic obstructive pulmonary disease (COPD) in people with multiple sclerosis: A systematic review and meta-analysis, Multiple Sclerosis and Related Disorders, 85, (105546), (2024).https://doi.org/10.1016/j.msard.2024.105546
    Crossref
  7. Neuropsychologie des instincts et des émotions, Neuropsychologie, (366-422), (2024).https://doi.org/10.1016/B978-2-294-78570-2.00018-6
    Crossref
  8. Assessment of sexual life and social life in people with multiple sclerosis, Health Promotion & Physical Activity, 21, 4, (38-45), (2023).https://doi.org/10.55225/hppa.476
    Crossref
  9. Immunosenescence: the role of age in multiple sclerosis, Neurología (English Edition), 38, 4, (284-290), (2023).https://doi.org/10.1016/j.nrleng.2020.05.023
    Crossref
  10. Inmunosenescencia: el rol de la edad en la esclerosis múltiple, Neurología, 38, 4, (284-290), (2023).https://doi.org/10.1016/j.nrl.2020.05.016
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share